The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

Patients with cardiovascular disease and, namely, heart failure are more susceptible to
coronavirus disease 2019 (COVID‐19) and have a more severe clinical course once …

Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …

The novel coronavirus 2019 (COVID-19) is clinically characterized by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for a high number …

Risk of MI after Acute Infection Among patients who are hospitalized for pneumococcal
pneumonia, the incidence of myocardial infarction is 7 to 8%. The true incidence of …

A close and intriguing relationship has been suggested between heart failure (HF) and
coronavirus disease 2019 (COVID-19). First, COVID-19 pandemic represented a global …

Aims To assess the prognostic value of a history of heart failure (HF) in patients with
coronavirus disease 2019 (COVID‐19). Methods and results We enrolled 692 consecutive …

Severe pneumonia is associated with high mortality (short and long term), as well as
pulmonary and extrapulmonary complications. Appropriate diagnosis and early initiation of …

Since an association between myocardial infarction (MI) and respiratory infections has been
described for influenza viruses and other respiratory viral agents, understanding possible …

Background Omadacycline, a new once-daily aminomethylcycline antibiotic agent that can
be administered intravenously or orally, reaches high concentrations in pulmonary tissues …